Social Experiences Switch States of Memory Engrams Through Regulating Hippocampal Rac1 Activity
Overview
Authors
Affiliations
In pathological or artificial conditions, memory can be formed as silenced engrams that are unavailable for retrieval by presenting conditioned stimuli but can be artificially switched into the latent state so that natural recall is allowed. However, it remains unclear whether such different states of engrams bear any physiological significance and can be switched through physiological mechanisms. Here, we show that an acute social reward experience switches the silent memory engram into the latent state. Conversely, an acute social stress causes transient forgetting via turning a latent memory engram into a silent state. Such emotion-driven bidirectional switching between latent and silent states of engrams is mediated through regulation of Rac1 activity–dependent reversible forgetting in the hippocampus, as stress-activated Rac1 suppresses retrieval, while reward recovers silenced memory under amnesia by inhibiting Rac1. Thus, data presented reveal hippocampal Rac1 activity as the basis for emotion-mediated switching between latent and silent engrams to achieve emotion-driven behavioral flexibility.
An "Engram-Centric" Approach to Transient Global Amnesia (TGA) and Other Acute-Onset Amnesias.
Larner A Neurol Int. 2025; 17(1).
PMID: 39852772 PMC: 11767542. DOI: 10.3390/neurolint17010008.
Natural forgetting reversibly modulates engram expression.
OLeary J, Bruckner R, Autore L, Ryan T Elife. 2024; 12.
PMID: 39499054 PMC: 11537488. DOI: 10.7554/eLife.92860.
If Engrams Are the Answer, What Is the Question?.
OSullivan F, Ryan T Adv Neurobiol. 2024; 38:273-302.
PMID: 39008021 DOI: 10.1007/978-3-031-62983-9_15.
Memory circuits in dementia: The engram, hippocampal neurogenesis and Alzheimer's disease.
Lazarov O, Gupta M, Kumar P, Morrissey Z, Phan T Prog Neurobiol. 2024; 236:102601.
PMID: 38570083 PMC: 11221328. DOI: 10.1016/j.pneurobio.2024.102601.
Active forgetting and neuropsychiatric diseases.
Berry J, Guhle D, Davis R Mol Psychiatry. 2024; 29(9):2810-2820.
PMID: 38532011 PMC: 11420092. DOI: 10.1038/s41380-024-02521-9.